Your session is about to expire
← Back to Search
Supervised walking on a treadmill for Type 2 Diabetes
Study Summary
This trial will study how well an exercise program improves cognition and brain health in people with type 2 diabetes, as well as how genetics may influence these effects.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have any other medical conditions or physical issues that might make it difficult for you to participate in exercise. This includes things like osteoporosis, asthma, or spinal cord injury.You experience chest pain and difficulty breathing during everyday activities.You have experienced losing consciousness or fainting, no matter the reason.
- Group 1: Attention control group
- Group 2: Aerobic exercise group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are enrollees still being welcomed into this trial?
"Affirmative. Clinicaltrials.gov data demonstrates that this research is currently recruiting volunteers, with the initial posting of it being on June 1st 2021 and its most recent edit on January 7th 2022. 84 individuals are required to be enrolled from a single site for this experiment."
What key goals is this research aiming to achieve?
"This clinical trial will last for a period of 3 months, and the primary objective is to evaluate working memory. Secondary endpoints include fasting blood glucose (measured by YSI), weight in kilograms (health scale) and plasma BDNF levels (ELISA kit)."
What is the aggregate assemblage of individuals involved in this experiment?
"That is correct. According to data found on clinicaltrials.gov, this experimental procedure was initially posted on June 1st 2021 and has most recently been updated January 7th 2022; 84 patients are sought from one location for the study's duration."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger